Gomes, Lenyta Oliveira <br/><br/>
Hepatitis C in Brazil: lessons learned with boceprevir and telaprevir.  [electronic resource] 

 -  Revista do Instituto de Medicina Tropical de Sao Paulo  2018 
 - e29 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1678-9946 
<br/><br/><label>Standard No.: </label>10.1590/s1678-9946201860029  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--administration & dosage<br/>Clinical Protocols<br/>Decision Making<br/>Drug Therapy, Combination<br/>Female<br/>Genotype<br/>Hepacivirus--genetics<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--administration & dosage<br/>Male<br/>Middle Aged<br/>Oligopeptides--administration & dosage<br/>Polyethylene Glycols--administration & dosage<br/>Proline--administration & dosage<br/>Protease Inhibitors--administration & dosage<br/>Recombinant Proteins--administration & dosage<br/>Retrospective Studies<br/>Ribavirin--administration & dosage